Tan et al. [15] proved that luteolin treatment could reduce oxidative stress, the inflammatory response, and neuronal apoptosis induced by ischemic stroke, which may be related to regulation of the NF-κB and MAPK pathways. This evidence concerns the gene NFKB1 and ischemic stroke.